LON:APH Alliance Pharma Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Alliance Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. GBX 112.80 +0.80 (+0.71%) (As of 07/4/2022 12:00 AM ET) Add Compare Share Today's Range 112.17▼ 113.8050-Day Range 108.20▼ 11652-Week Range 95.50▼ 123Volume172,859 shsAverage Volume998,674 shsMarket Capitalization£608.83 millionP/E Ratio11,280.00Dividend Yield1.51%Price TargetGBX 137.50 ProfileAnalyst RatingsChartCompetitorsDividendInsider TradesHeadlinesOptions Chain Alliance Pharma MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside21.9% UpsideGBX 137.50 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.1.17 out of 5 stars 2.5 Analyst's Opinion Consensus RatingAlliance Pharma has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 137.50, Alliance Pharma has a forecasted upside of 21.9% from its current price of GBX 112.80.Amount of Analyst CoverageAlliance Pharma has only been the subject of 1 research reports in the past 90 days. Previous Next 0.0 Short Interest Short InterestThere is no current short interest data available for APH. Previous Next 0.8 Dividend Strength Dividend YieldAlliance Pharma pays a meaningful dividend of 1.51%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthAlliance Pharma does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Alliance Pharma is 163.70%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for APH. Previous Next 1.7 News and Social Media Coverage News SentimentAlliance Pharma has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies.Search Interest9 people have searched for APH on MarketBeat in the last 30 days. This is an increase of 350% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Alliance Pharma insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Alliance Pharma is 11,280.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 76.62.Price to Earnings Ratio vs. SectorThe P/E ratio of Alliance Pharma is 11,280.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 82.67.Price to Earnings Growth RatioAlliance Pharma has a PEG Ratio of 2.99. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAlliance Pharma has a P/B Ratio of 2.15. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive APH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alliance Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address About Alliance Pharma (LON:APH) StockAlliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.Read More APH Stock News HeadlinesJune 17, 2022 | americanbankingnews.comAlliance Pharma's (APH) Buy Rating Reaffirmed at Berenberg BankJune 2, 2022 | uk.finance.yahoo.comThe Alliance Pharma share price – where next?May 16, 2022 | finance.yahoo.comInvestors in Alliance Pharma (LON:APH) have made a solid return of 148% over the past five yearsMay 14, 2022 | fool.co.uk7 top AIM market shares to buy nowMarch 26, 2022 | finance.yahoo.comCan Mixed Fundamentals Have A Negative Impact on Alliance Pharma plc (LON:APH) Current Share Price Momentum?January 19, 2022 | lse.co.ukAlliance Pharma earnings up on increased revenue, e-commerce activityJanuary 19, 2022 | finance.yahoo.comIs There An Opportunity With Alliance Pharma plc's (LON:APH) 48% Undervaluation?December 4, 2021 | finance.yahoo.comThose who invested in Alliance Pharma (LON:APH) five years ago are up 152%November 6, 2021 | ca.finance.yahoo.comAlliance Pharma plc (APH.L)September 12, 2021 | finance.yahoo.comCan Alliance Pharma plc (LON:APH) Performance Keep Up Given Its Mixed Bag Of Fundamentals?August 14, 2021 | fool.co.uk2 nearly penny stocks to buy in SeptemberAugust 2, 2021 | finance.yahoo.comHow Many Alliance Pharma plc (LON:APH) Shares Do Institutions Own?June 29, 2021 | lse.co.ukEXECUTIVE CHANGES: Greencare Capital chair retires after May promotionJune 27, 2021 | finance.yahoo.comAnnouncing: Alliance Pharma (LON:APH) Stock Increased An Energizing 121% In The Last Five YearsJune 3, 2021 | lse.co.ukAlliance Pharma Regulatory NewsMay 14, 2021 | finance.yahoo.comAre Investors Undervaluing Alliance Pharma plc (LON:APH) By 44%?May 12, 2021 | markets.businessinsider.comAlliance Pharma PLC : Notice of AGMApril 23, 2021 | fool.co.ukShould I buy penny share Alliance Pharma?April 8, 2021 | proactiveinvestors.comAlliance Pharma now has consumer healthcare front and centreMarch 30, 2021 | finance.yahoo.comAlliance Pharma plc's (LON:APH) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?March 29, 2021 | lse.co.ukBROKER RATINGS: Morgan Stanley upgrades BT to OverweightMarch 24, 2021 | lse.co.ukIndivior revamps board after accord with biggest shareholder ScopiaFebruary 10, 2021 | ft.comIndia, Covid-19 and vaccine politicsFebruary 8, 2021 | lse.co.uk4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma DrugFebruary 4, 2021 | msn.comWhy the EU has fallen behind on vaccinesSee More Headlines Industry, Sector and Symbol Stock ExchangeLON Industry Drugs - Generic Sub-IndustryN/A SectorMedical Current SymbolLON:APH CUSIPN/A CIKN/A Webwww.alliancepharma.co.uk Phone+44-1249-466966FaxN/AEmployees256Year FoundedN/ACompany Calendar Ex-Dividend for 7/7 Dividend6/09/2022Today7/04/2022Dividend Payable7/07/2022Next Earnings (Estimated)9/19/2022Price Target and Rating Average Stock Price ForecastGBX 137.50 High Stock Price ForecastGBX 145 Low Stock Price ForecastGBX 130 Forecasted Upside/Downside+21.9%Consensus RatingBuy Rating Score (0-4)3 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio11,280.00 Forward P/E Ratio16.13 P/E Growth2.99Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio42.11 Current Ratio2.00 Quick Ratio1.40 Sales & Book Value Annual Sales£163.21 million Price / Sales3.73 Cash FlowGBX 5.38 per share Price / Cash Flow20.96 Book ValueGBX 52.50 per share Price / Book2.15Miscellaneous Outstanding Shares539,742,000Free FloatN/AMarket Cap£608.83 million OptionableOptionable BetaN/A Alliance Pharma Frequently Asked Questions Should I buy or sell Alliance Pharma stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alliance Pharma in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Alliance Pharma stock. View analyst ratings for Alliance Pharma or view top-rated stocks. What is Alliance Pharma's stock price forecast for 2022? 2 brokers have issued 1 year price targets for Alliance Pharma's stock. Their APH stock forecasts range from GBX 130 to GBX 145. On average, they predict Alliance Pharma's share price to reach GBX 137.50 in the next year. This suggests a possible upside of 21.9% from the stock's current price. View analysts' price targets for Alliance Pharma or view top-rated stocks among Wall Street analysts. How has Alliance Pharma's stock performed in 2022? Alliance Pharma's stock was trading at GBX 108.80 at the beginning of the year. Since then, APH stock has increased by 3.7% and is now trading at GBX 112.80. View the best growth stocks for 2022 here. When is Alliance Pharma's next earnings date? Alliance Pharma is scheduled to release its next quarterly earnings announcement on Monday, September 19th 2022. View our earnings forecast for Alliance Pharma. How often does Alliance Pharma pay dividends? What is the dividend yield for Alliance Pharma? Alliance Pharma declared a dividend on Tuesday, March 22nd. Shareholders of record on Thursday, June 9th will be given a dividend of GBX 1.13 per share on Thursday, July 7th. This represents a dividend yield of 1.01%. The ex-dividend date of this dividend is Thursday, June 9th. This is a boost from Alliance Pharma's previous dividend of GBX 0.56. The official announcement can be viewed at this link. View Alliance Pharma's dividend history. Is Alliance Pharma a good dividend stock? Alliance Pharma(LON:APH) pays an annual dividend of GBX 0.02 per share and currently has a dividend yield of 1.51%. The dividend payout ratio of Alliance Pharma is 163.70%. Payout ratios above 75% are not desirable because they may not be sustainable. View Alliance Pharma's dividend history. Who are Alliance Pharma's key executives? Alliance Pharma's management team includes the following people: Mr. Peter Jonathan Butterfield, CEO & Exec. Director (Age 46, Pay $978.91k)Mr. Andrew Timothy Franklin, CFO & Exec. Director (Age 56, Pay $417.2k)Mr. Stephen Kidner, Chief Scientific Affairs & Operations OfficerMs. Cora Maeve McCallum C.F.A., Head of Investor Relations & Corp. CommunicationsMr. Alex Duggan, Chief Commercial & Corp. Devel. OfficerMs. Janice Timberlake, Chief People & Infrastructure OfficerMr. Steve Lobb, Head of HydromolMr. David Hope, Head of Secondary CareMr. Rajiv Ghidiyal, Head of APAC, EMEA & AmericasMr. Karim Husny, Head of International Who are some of Alliance Pharma's key competitors? Some companies that are related to Alliance Pharma include Fate Therapeutics (FATE), Integer (ITGR), HUTCHMED (HCM), ACADIA Pharmaceuticals (ACAD), Definitive Healthcare (DH), National Vision (EYE), Arvinas (ARVN), Glaukos (GKOS), Cano Health (CANO), EQRx (EQRX), Oxford Nanopore Technologies (ONT), dentalcorp (DNTL), Alignment Healthcare (ALHC), Apollo Medical (AMEH) and Indivior (INDV). View all of APH's competitors. What other stocks do shareholders of Alliance Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Alliance Pharma investors own include RPC Group (RPC), American Airlines Group (AAL), BlackBerry (BB), Editas Medicine (EDIT), 1-800-FLOWERS.COM (FLWS), Air Canada (AC), Ally Financial (ALLY), Aviva (AV), BAE Systems (BA) and Berry Global Group (BERY). What is Alliance Pharma's stock symbol? Alliance Pharma trades on the London Stock Exchange (LON) under the ticker symbol "APH." How do I buy shares of Alliance Pharma? Shares of APH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Alliance Pharma's stock price today? One share of APH stock can currently be purchased for approximately GBX 112.80. How much money does Alliance Pharma make? Alliance Pharma (LON:APH) has a market capitalization of £608.83 million and generates £163.21 million in revenue each year. How many employees does Alliance Pharma have? Alliance Pharma employs 256 workers across the globe. How can I contact Alliance Pharma? Alliance Pharma's mailing address is Avonbridge House, Bath Road, CHIPPENHAM, SN15 2BB, United Kingdom. The official website for Alliance Pharma is www.alliancepharma.co.uk. The company can be reached via phone at +44-1249-466966. This page (LON:APH) was last updated on 7/4/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
